DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
von Minckwitz G. Hahnen E. Fasching PA.
Pathological complete response (pCR) rates after carboplatin-containing neoadjuvant chemotherapy in patients with germline BRCA (gBRCA) mutation and triple-negative breast cancer (TNBC): Results from GeparSixto.
J Clin Oncol 2014;
32: 5s (suppl; abstr 1005)
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.